Company / AR per Share
Wave Life Sciences Ltd. AR per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.01
FY2025
5-year range
$0.01 / $0.24
FY2021-FY2025
Trend
-30.1%
vs FY2024
Sector context
#108 of 113
Health Care
What the data says
Among 113 Health Care companies, Wave Life Sciences Ltd. is in the bottom 4% for ar per share. AR per Share has declined for 3 consecutive years, from $0.87 in FY2020 to $0.01 in FY2025.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of -60.6%.
Declined from $0.24 to $0.01 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -60.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 113This company $0.01 Sector average $28.83
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, ar per share decreased 30.1% year-over-year.
- Ranks #108 out of 113 companies in the Health Care sector.
- Peak ar per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -30.1% |
| FY2024 | $0.01 | -95.1% |
| FY2023 | $0.24 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $0.87 | +28.7% |
| FY2019 | $0.68 | +88.8% |
| FY2018 | $0.36 | +744.5% |
| FY2017 | $0.04 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026